Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0000950135-99-001739
Filing Date
1999-03-31
Accepted
1999-03-31 00:00:00
Documents
6
Period of Report
1998-12-31

Document Format Files

Seq Description Document Type Size
1 ORAVAX, INC. 10-K 313140
2 LICENSE AGREEMENT W/PASTEUR MERIEUX CONNAUGHT EX-10.01 73971
3 AMENDMENT AGREEMENT & FACILITY LETTER EX-10.02 42832
4 LOAN AGREEMENT W/PEPTIDE THERAPEUTICS GROUP PLC EX-10.03 95484
5 FIRST AMENDMENT TO FACILITY AGREEMENT EX-10.04 10432
6 FINANCIAL DATA SCHEDULE EX-27 2055
  Complete submission text file 0000950135-99-001739.txt   539808
Mailing Address
Business Address 38 SIDNEY ST 4TH FLOOR CAMBRIDGE MA 02139 6175266000
ORAVAX INC /DE/ (Filer) CIK: 0000900122 (see all company filings)

EIN.: 043085209 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-26034 | Film No.: 99581440
SIC: 2836 Biological Products, (No Diagnostic Substances)